Atom Investors’s Alto Neuroscience ANRO Stock Holding History

Atom Investors’s Portfolio ANRO Stock Details ANRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-10,419	Closed	-$44.1K	–	661
2024 Q4	$44.1K	Buy	+10,419	New	+$65K	0.01%	474

Other funds holding ANRO

AWG

Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Atom Investors's ANRO Position: Q1 2025 in Review

Atom Investors sold out of Alto Neuroscience (ANRO) in Q1 2025, closing a stake of 10,419 shares — an estimated $44.1K sold.

Atom Investors first reported a position in ANRO in Q4 2024 and held it in 1 quarter. The position peaked at $44.1K in Q4 2024. 83 funds tracked by Wall St. Rank hold ANRO as of Q1 2025.

Atom Investors reported no remaining Alto Neuroscience position as of Q1 2025 after selling out during the quarter.
Atom Investors sold 10,419 Alto Neuroscience shares in Q1 2025, an estimated $44.1K.
Atom Investors first reported a position in Alto Neuroscience in Q4 2024 and held it in 1 quarter.
Atom Investors's Alto Neuroscience position peaked at $44.1K in Q4 2024.
83 funds tracked by Wall St. Rank held Alto Neuroscience as of Q1 2025.

Based on Atom Investors's 13F filing for Q1 2025, filed 15 May 2025.